Trademark: 97408278
Word
XYMBISPHERE
Status
Pending
Status Code
730
Status Date
Wednesday, February 14, 2024
Serial Number
97408278
Mark Type
4000
Filing Date
Thursday, May 12, 2022
Published for Opposition
Tuesday, July 18, 2023

Trademark Owner History
AstraZeneca AB - Owner At Publication

Classifications
5 Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, neurological, gastrointestinal and immune systems; Pharmaceutical preparations and substances for the treatment of infection, inflammation, hematological, autoimmune related diseases and disorders; Pharmaceutical preparations and substances, namely, antibodies; vaccines

Trademark Events
Feb 15, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 14, 2024
Sou Extension 1 Granted
Feb 14, 2024
Sou Extension 1 Filed
Feb 14, 2024
Sou Teas Extension Received
Sep 12, 2023
Noa E-Mailed - Sou Required From Applicant
Jul 18, 2023
Official Gazette Publication Confirmation E-Mailed
Jul 18, 2023
Published For Opposition
Jun 28, 2023
Notification Of Notice Of Publication E-Mailed
Jun 14, 2023
Approved For Pub - Principal Register
Jun 6, 2023
Teas/Email Correspondence Entered
Jun 5, 2023
Correspondence Received In Law Office
Jun 5, 2023
Teas Response To Office Action Received
Mar 3, 2023
Application Extension Granted/Receipt Provided
Mar 3, 2023
Application Extension To Response Period - Received
Dec 16, 2022
Notification Of Non-Final Action E-Mailed
Dec 16, 2022
Non-Final Action E-Mailed
Dec 16, 2022
Non-Final Action Written
Dec 12, 2022
Assigned To Examiner
May 17, 2022
New Application Office Supplied Data Entered
May 16, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24